Shelter Pharma Secures ₹27,540 Order from Sudan Partner for D3 Cure Capsules

1 min read Updated on 16 Dec 2025, 11:17 AM

Reviewed by

Jubin VScanX News Team

Overview

Shelter Pharma Limited announced securing another international order worth ₹27,540 from Sudan-based Taha Drugs & Chemicals Co. Ltd for D3 Cure Capsules. This represents the third order from the same client, following previous orders worth ₹98,875 and ₹27,600, demonstrating continued business expansion in international markets with execution timeline of 2 months.

*this image is generated using AI for illustrative purposes only.

Shelter Pharma Limited , a pharmaceutical and nutraceutical company, has announced securing another international order from Taha Drugs & Chemicals Co. Ltd, a Sudan-based entity. The latest order is worth ₹27,540 for D3 Cure Capsules, adding to the company's growing international business portfolio.

Latest Order Details

The recent order announcement provides the following specifications:

Aspect:	Details
Product:	D3 Cure Capsules
Order Value:	₹27,540
Execution Timeline:	Within 2 months
Client Location:	Sudan (International entity)
Related Party Transaction:	No

Previous Order History

This marks the third order from the same Sudan-based client, demonstrating a continued business relationship with the international partner. The company has previously secured orders including one worth ₹98,875 for Joemega Capsules and Vitamin Tablets, and another worth ₹27,600 for Joemega Capsules.

Order Comparison:	Previous Orders	Latest Order
Order Values:	₹98,875 & ₹27,600	₹27,540
Products:	Joemega Capsules & Vitamin Tablets	D3 Cure Capsules
Timeline:	Within 2 months	Within 2 months

Regulatory Compliance

Shelter Pharma Limited has confirmed that this latest order does not constitute a related party transaction. The company's promoters have no interest in Taha Drugs & Chemicals Co. Ltd, ensuring transparency in operations and compliance with regulatory requirements under SEBI regulations.

Company Profile

Shelter Pharma Limited positions itself as a leading pharmaceutical and nutraceutical company dedicated to research, innovation, and quality healthcare solutions. The company operates state-of-the-art facilities and maintains a commitment to ethical practices, focusing on producing safe and effective products that enhance quality of life globally.

These consecutive orders from the Sudan-based partner indicate strengthening international relationships and demonstrate the company's ability to secure diverse product orders across different therapeutic segments, which may contribute positively to the company's financial performance.

Historical Stock Returns for Shelter Pharma

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-100.00%	-0.57%	-20.05%	-26.86%	-21.52%	-21.33%

Shelter Pharma

View Company Insights

View All News

Shelter Pharma Launches D3 Cure Capsules to Address Vitamin D Deficiency Market

2 min read Updated on 15 Dec 2025, 03:04 PM

Reviewed by

Radhika SScanX News Team

Add as a preferred
source on Google

Overview

Shelter Pharma has officially launched D3 Cure Capsules to address the growing vitamin D deficiency market, leveraging six decades of natural healing expertise. The comprehensive health supplement targets multiple benefits including bone health, immune support, mental wellness, and chronic condition management, positioning the company for sustained growth in the international nutraceutical sector.

*this image is generated using AI for illustrative purposes only.

Shelter Pharma has officially announced the launch of D3 Cure Capsules through a press release dated December 15, 2025, marking a significant expansion of its nutraceutical portfolio. The pharmaceutical company, with six decades of experience in natural healing, is strategically positioning itself to tap into the rapidly growing international vitamin D supplementation market.

Company Heritage and Vision

Shelter Pharma has spent the last six decades championing natural healing, guided by principles of tradition, integrity, and continuous progress. Since its humble beginning in 1965, the company has grown with a deep commitment to nature, blending traditional wisdom with a modern, forward-looking approach. The company combines extensive research and development with state-of-the-art technology while remaining dedicated to the natural way of healing.

Product Launch Details

The D3 Cure Capsules represent Shelter Pharma's strategic entry into addressing vitamin D deficiency, one of the most common nutritional deficiencies globally. The primary benefit of these capsules is the prevention and treatment of vitamin D deficiency, playing a crucial role in helping the body absorb calcium and phosphorus essential for maintaining overall health.

Product Details:	Information
Product Name:	D3 Cure Capsules
Launch Date:	December 15, 2025
Category:	Nutraceutical
Primary Target:	Vitamin D Deficiency Prevention & Treatment
Market Focus:	International Wellness Market

Comprehensive Health Benefits

The D3 Cure Capsules provide several significant health benefits across multiple body systems. The product supports bone health by aiding calcium absorption, helping maintain strong and healthy bones while reducing fracture risk. It is specifically used to manage conditions like osteoporosis, osteomalacia, and rickets in children.

Health Benefits:	Applications
Bone Health:	Manages osteoporosis, osteomalacia, rickets
Immune System:	Increases resistance to infections and illnesses
Mental Health:	May improve mood and mental well-being
Muscle Function:	Reduces muscle pain and weakness
Chronic Conditions:	Aids rheumatoid arthritis and multiple sclerosis treatment
Cardiovascular:	Helps regulate blood pressure

Strategic Market Positioning

This launch is part of Shelter Pharma's comprehensive strategy to expand its nutraceutical portfolio and strengthen its presence in the wellness and preventive healthcare segment. The company believes the launch of D3 Cure Capsules will contribute positively to its growth prospects and reinforce its commitment to providing high-quality, science-backed nutritional solutions.

The company continues to focus on building a diverse portfolio of high-quality, accessible wellness products that cater to evolving consumer needs. As it deepens its presence in the nutraceutical sector, Shelter Pharma is positioned to deliver sustained growth, strengthen brand equity, and create long-term value for customers, partners, and investors alike.

Historical Stock Returns for Shelter Pharma